The global neurostimulation industry is projected to experience substantial growth, with its valuation expected to rise from USD 6,221.2 million in 2023 to an estimated USD 15,417.4 million by 2033. This expansion reflects a promising compound annual growth rate (CAGR) of 9.5% during the forecast period, driven by the increasing prevalence of neurological disorders and rising demand for advanced, non-invasive treatment options.
Neurostimulation technology involves the use of electrical impulses to stimulate specific regions of the brain or nervous system, offering effective treatment for a range of conditions, including chronic pain, epilepsy, Parkinson’s disease, and depression. The market is being fueled by advancements in device technologies, such as the development of smaller, more efficient implants, and innovations in wearable neurostimulators that offer greater comfort and accessibility.
The increasing acceptance of neurostimulation therapies as an alternative to traditional drug treatments is also contributing to the market’s growth. As healthcare providers seek to improve patient outcomes while minimizing side effects, neurostimulation continues to gain traction as a viable and effective solution.
A Full Report Overview – https://www.futuremarketinsights.com/reports/neurostimulation-market
Key Takeaways:
- Market Growth: The neurostimulation market is expected to grow at a 9.5% CAGR, reaching USD 15.4 billion by 2033.
- Key Drivers: Rising prevalence of neurological disorders, technological advancements in neurostimulation devices, and growing demand for non-invasive therapies are driving the market.
- Technological Advancements: Innovations in device design, wearable neurostimulators, and personalized treatment options are transforming the neurostimulation landscape.
- Future Outlook: With expanding applications and continued technological breakthroughs, the neurostimulation market is positioned for transformative growth in the coming years.
The expected growth of the neurostimulation market highlights its growing importance in the treatment of neurological conditions, offering patients innovative, effective, and non-invasive alternatives to traditional therapies.
Regional Insights
- North America is anticipated to dominate the neurostimulation market, driven by high healthcare spending and a strong presence of key players.
- The Asia-Pacific region is expected to exhibit significant growth due to increasing healthcare investments and a rising prevalence of neurological disorders.
Key Trends Impacting Sales of Neurostimulation Devices
- Key players are developing neurostimulation devices that can be prescribed by health professionals for remote use. Portable neurostimulation devices for Parkinson’s, back pain, etc., have been introduced for faster patient outcomes.
- Increasing research and development efforts in neurostimulation to arrive at new applications and treat disorders like autism, stroke, sleep disorders, obesity, and several others are predicted to elevate the scope of neurostimulation.
- Rising demand for technologies that offer better outcomes, optimized inter-device communication, neurological episode on-set, and better user interface.
- Soaring levels of the geriatric population, with higher risks of neurological disorders like epilepsy, essential tremors, Parkinson’s disease, and depression-related disorders, are predicted to boost the demand for neurostimulation.
- Increasing acceptance of neurostimulation systems and devices to treat chronic pain, particularly in emerging economies like China, India, Brazil, etc.
- The rise in the clearance from the FDA for innovative neurostimulators with new applications is enhancing the market scope for neurostimulation.
Competitive Landscape in the Neurostimulation Market
Key players in the neurostimulation market are focusing on product development, which caters to more applications meanwhile enhancing these devices’ efficiency, effectiveness, and user-friendliness. Apart from this, companies are leading clinical trials to test the efficacy and safety of their devices, boosting customer confidence and obtaining regulatory approvals for their neurostimulation devices.
Market participants are significantly investing in the sales and marketing of their product portfolio to healthcare professionals. This includes developing educational materials and exhibiting at trade shows for businesses. Additionally, companies are forming alliances with other players to extend their market reach as well as product portfolio.
Key Developments Observed in the Neurostimulation Market
- In September 2023, a collaborative study including the universities of Surrey and Oxford, Radboud University, and Loughborough University was conducted to explore the scope of neurostimulation to boost mathematical learning. For this, high-frequency transcranial random noise stimulation was applied to stimulate certain brain regions and enhance the mathematical capabilities of participants. The research suggests a positive impact of brain stimulation on mathematical skills.
- In April 2023, Neuspera Medical obtained FDA approval for a micro-implant neurostimulation therapy system. The system deploys a wearable device and a wireless platform for peripheral nerve stimulation.
- In December 2022, the American Association for the Advancement of Science announced the development of new neurostimulation technology for advancements in the research and treatment of Parkinson’s disease. Latest innovations in DBS stimulators have opened doors to research the results of the recent DBS advances on Parkinson’s disease.
Key Players in the Neurostimulation Market
- Boston Scientific Corporation
- Cyberonics Inc.
- St. Jude Medical Inc.
- Medtronic Inc.
- NeuroPace Inc.
- NeuroSigma, Inc.
- Others
Key Segments
By Type:
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Others
By Application:
- Pain Management
- Hearing Loss
- Urinary Incontinence
- Parkinson’s disease
- Epilepsy
- Others
By Region:
- North America
- Latin America
- Asia Pacific
- Japan
- Western Europe
- Eastern Europe
- Middle East & Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube